Microbix Biosystems Inc. (MBX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Microbix Biosystems Inc. (MBX) has a cash flow conversion efficiency ratio of -0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-466.81K ≈ $-337.69K USD) by net assets (CA$24.26 Million ≈ $17.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MBX company net worth for the company's overall valuation and market capitalisation.
Microbix Biosystems Inc. - Cash Flow Conversion Efficiency Trend (1997–2025)
This chart illustrates how Microbix Biosystems Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Microbix Biosystems Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Microbix Biosystems Inc. ranked by their cash flow conversion efficiency. Explore MBX cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aurora Mobile Ltd
NASDAQ:JG
|
0.048x |
|
China Crystal New Material
KQ:900250
|
-0.016x |
|
Asuransi Harta Aman Pratama Tbk PT
JK:AHAP
|
0.088x |
|
HI SPAC 3
KQ:217500
|
-0.025x |
|
Etiler İnci Bufe Gida Sanayi ve Dis Ticaret AS
IS:ETILR
|
-0.381x |
|
Bumi Teknokultura Unggul Tbk
JK:BTEK
|
-0.028x |
|
E4U a.s.
PR:EFORU
|
N/A |
|
Partnera Oyj
HE:PARTNE1
|
0.030x |
Annual Cash Flow Conversion Efficiency for Microbix Biosystems Inc. (1997–2025)
The table below shows the annual cash flow conversion efficiency of Microbix Biosystems Inc. from 1997 to 2025. View Microbix Biosystems Inc. (MBX) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | CA$27.79 Million ≈ $20.10 Million |
CA$-80.29K ≈ $-58.08K |
-0.003x | -101.88% |
| 2024-09-30 | CA$28.30 Million ≈ $20.47 Million |
CA$4.35 Million ≈ $3.15 Million |
0.154x | +445.65% |
| 2023-09-30 | CA$24.62 Million ≈ $17.81 Million |
CA$-1.09 Million ≈ $-791.79K |
-0.044x | -131.99% |
| 2022-09-30 | CA$24.94 Million ≈ $18.04 Million |
CA$3.47 Million ≈ $2.51 Million |
0.139x | +22.39% |
| 2021-09-30 | CA$18.56 Million ≈ $13.42 Million |
CA$2.11 Million ≈ $1.52 Million |
0.114x | +8673.40% |
| 2020-09-30 | CA$6.62 Million ≈ $4.79 Million |
CA$8.57K ≈ $6.20K |
0.001x | -69.27% |
| 2019-09-30 | CA$10.54 Million ≈ $7.62 Million |
CA$44.37K ≈ $32.10K |
0.004x | +108.12% |
| 2018-09-30 | CA$10.35 Million ≈ $7.49 Million |
CA$-537.00K ≈ $-388.46K |
-0.052x | -364.96% |
| 2017-09-30 | CA$15.17 Million ≈ $10.98 Million |
CA$297.05K ≈ $214.88K |
0.020x | -67.22% |
| 2016-09-30 | CA$15.29 Million ≈ $11.06 Million |
CA$913.31K ≈ $660.67K |
0.060x | +37.19% |
| 2015-09-30 | CA$13.68 Million ≈ $9.89 Million |
CA$595.40K ≈ $430.70K |
0.044x | +136.59% |
| 2014-09-30 | CA$9.84 Million ≈ $7.12 Million |
CA$-1.17 Million ≈ $-846.97K |
-0.119x | -258.89% |
| 2013-09-30 | CA$5.72 Million ≈ $4.14 Million |
CA$428.36K ≈ $309.87K |
0.075x | +117.64% |
| 2012-09-30 | CA$4.12 Million ≈ $2.98 Million |
CA$-1.75 Million ≈ $-1.27 Million |
-0.425x | -68.21% |
| 2011-09-30 | CA$5.15 Million ≈ $3.72 Million |
CA$-1.30 Million ≈ $-939.78K |
-0.252x | +21.42% |
| 2010-09-30 | CA$5.65 Million ≈ $4.09 Million |
CA$-1.81 Million ≈ $-1.31 Million |
-0.321x | +5.76% |
| 2009-09-30 | CA$6.41 Million ≈ $4.64 Million |
CA$-2.19 Million ≈ $-1.58 Million |
-0.341x | -32.97% |
| 2008-09-30 | CA$7.62 Million ≈ $5.51 Million |
CA$-1.95 Million ≈ $-1.41 Million |
-0.256x | +67.62% |
| 2007-09-30 | CA$2.28 Million ≈ $1.65 Million |
CA$-1.81 Million ≈ $-1.31 Million |
-0.792x | +25.75% |
| 2006-09-30 | CA$1.48 Million ≈ $1.07 Million |
CA$-1.58 Million ≈ $-1.14 Million |
-1.066x | -892.57% |
| 2005-09-30 | CA$2.77 Million ≈ $2.00 Million |
CA$372.31K ≈ $269.32K |
0.135x | -30.91% |
| 2004-09-30 | CA$2.28 Million ≈ $1.65 Million |
CA$444.57K ≈ $321.60K |
0.195x | +280.59% |
| 2003-09-30 | CA$1.99 Million ≈ $1.44 Million |
CA$-214.27K ≈ $-155.00K |
-0.108x | -315.02% |
| 2002-09-30 | CA$2.12 Million ≈ $1.53 Million |
CA$106.20K ≈ $76.82K |
0.050x | -70.95% |
| 2001-09-30 | CA$2.05 Million ≈ $1.48 Million |
CA$353.56K ≈ $255.76K |
0.173x | +334.02% |
| 2000-09-30 | CA$1.76 Million ≈ $1.28 Million |
CA$-130.02K ≈ $-94.06K |
-0.074x | +90.36% |
| 1999-09-30 | CA$1.70 Million ≈ $1.23 Million |
CA$-1.30 Million ≈ $-940.40K |
-0.765x | -25.49% |
| 1998-09-30 | CA$6.40 Million ≈ $4.63 Million |
CA$-3.90 Million ≈ $-2.82 Million |
-0.609x | -2337.50% |
| 1997-09-30 | CA$8.00 Million ≈ $5.79 Million |
CA$-200.00K ≈ $-144.68K |
-0.025x | -- |
About Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays… Read more